Wyeth launches China's first infant formula with two types of HMOs, leading the way in HMO innovation

2024-03-25
临床研究上市批准
SHANGHAI, March 25, 2024 /PRNewswire/ -- Filling a gap in the local HMO market, the recently released illuma HMO Liquid Formula is the first in China to contain two essential HMOs, 2'-Fucosyllactose (2'-FL) and Lacto-N-neotetraose (LNnT). This clinically proven product offers substantial advantages for the general well-being of newborns between the ages of 0 and 12 months. It diminishes lower respiratory tract infections by 55%, bronchitis by 70%, and the likelihood of using antibiotics by 53%.
Continue Reading
Wyeth launches China's first infant formula with two types of HMOs, leading the way in HMO innovation
Preview
来源: PRNewswire
illuma HMO Liquid Formula
Meanwhile, based on this ground-breaking innovation, the domestic HMO clinical study project for Chinese infants has officially started. Nestlé Research & Development (China) and Wyeth Nutrition are the project's sponsors. Shanghai Jiao Tong University School of Medicine's Xinhua Hospital is in charge of the endeavor. Collaborating with clinical centers in elite hospitals around the country, the project aims to verify the clinical effectiveness of the two HMOs that have been approved for Chinese infants. This will ensure that more Chinese babies can timely and continuously benefit from the early-life health benefits that HMOs bring.
Ms. Shiela Qiu, Regional Business Head, Wyeth Nutrition Greater China Region, stated, "We are thrilled to achieve another milestone in the Chinese infant nutrition market. Wyeth Nutrition's dominant position in the global human milk oligosaccharide (HMO) industry is further evidenced by the introduction of China's first HMO-infused infant formula, which contains two different kinds of HMOs. Wyeth Nutrition is dedicated to fostering the superior growth of the Chinese infant nutrition market, bringing together worldwide research resources and quickening local innovation, and offering Chinese newborns more complete early-life nutrition options."
SOURCE Wyeth Nutrition
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。